News

In his presentation at Winter Clinical Miami, Del Rosso covered a variety of topics including refractory pediatric vitiligo.

Biologic coordinators play a key role in managing insurance approvals and ensuring coverage details are confirmed quickly, often within 48 hours.

The IL-36R antagonist has demonstrated its safety and efficacy for generalized pustular psoriasis in GEMINI-1 and GEMINI-2 studies.

Answer today’s poll and read more about the validity of dermatological content being shared on TikTok.

The clinically-backed, post-procedure sunscreen is designed to enhance skin healing, reduce redness, promote hydration, and provide broad-spectrum UV protection.

Dermatology Times has compiled a list of dermatological meetings taking place during the month of February.

Explore the top headlines of the week including innovation in scalp treatment, therapeutic updates in rosacea, and acne vulgaris insights from James Del Rosso, DO.

In case you missed it, this week we had news about awareness resources from the Skin Cancer Foundation, burn care disparities in skin of color, aesthetic insights for patients on medication-driven weight loss journeys, and more.

As newly appointed Executive Director of the Foundation, Becky Kamowitz is combining public education with clinical needs in the fight against skin cancer.

Pilot and research grants may be awarded to research on keratinocyte biology and differentiation, genetics, biology of skin inflammation, itch, or other ichthyosis-related areas.

In an interview with Dermatology Times, Del Rosso shared the latest in the treatment landscape for patients with Darier disease.

Learn more about the in-depth topics covered in the January 2025 print issue of Dermatology Times.

A recent study found standard burn assessment tools often fail to accurately evaluate injuries in darker skin tones, leading to misdiagnosis and delays.

Researchers found that PsA patients prioritize fatigue, sleep issues, and uncertainty, often ranking them higher than doctors do.

There are numerous ways for dermatologists to get involved in initiatives from the Skin Cancer Foundation, according to Becky Kamowitz.

Patients with hidradenitis suppurativa experience knowledge gaps on effective treatments and addressing these gaps could help prevent tissue damage among patients.

This innovative approach to multimodal aesthetics care was announced at IMCAS World Congress 2025.

Dermatology Times is looking back on the top stories in dermatology from the month of January.

Del Rosso outlined new and off-label therapies for the disease that he shared in his presentation at Winter Clinical Miami.

The Pillars of Confidence global study assessed the role that confidence plays in daily life and how aesthetic treatments affect confidence.

In an interview with Dermatology Times, Del Rosso gave insight on off-label therapies that could be used to treat granuloma annulare.

The meta-analysis found that HA fillers enhance skin hydration and glow, but do not significantly impact elasticity.

“The Big See” campaign and the Seal of Recommendation program are just 2 examples of initiatives led by the Skin Cancer Foundation.

85% of Chinese PN patients saw a PP-NRS improvement of ≥ 4 points after 12 weeks of treatment.

Dermatology Times is recapping our top expert interviews from the month of January.

Discover insights from Gerry Muhle and Michael Somenek, MD, on regenerative aesthetics, weight-loss impacts, and trends shaping facial rejuvenation.

James Del Rosso, DO, explored the treatment landscape and the importance of regular eye exams for patients with AD.

The Foundation’s extensive library includes brochures, magazines, and posters to promote education among dermatologists and patients.

Investigators observed lowered MASI and PGA scores in the side of the face treated with BoNT-A.

As a part of his presentation at Winter Clinical Miami, Del Rosso discussed new and emerging therapies for acne vulgaris.